Health Ventures
Growth-stage capital for healthcare, diagnostics and life sciences businesses.
Strategies / Ventures
Overview
Health Ventures backs companies improving clinical outcomes and the economics of care delivery — diagnostics, medical devices, healthcare services and digital health platforms.
We invest at the point where clinical validation exists and the challenge becomes commercialisation: reimbursement pathways, regulatory approvals, manufacturing scale and clinician adoption.
Healthcare demands specialist underwriting. Our team assesses clinical evidence, payer dynamics and regulatory risk alongside conventional commercial diligence.
Growth-stage
Entry point
Clinically validated
Minimum standard
Global
Market ambition
What We Look For
- Diagnostics and medical devices with regulatory clearance pathways
- Healthcare services and specialist clinical networks
- Digital health and clinical software
- Life sciences tools and manufacturing
Our Approach
Clinical diligence
Independent clinical and scientific advisory review of evidence.
Reimbursement
Payer and coding strategy mapped before capital is committed.
Regulatory
TGA, FDA and CE pathway planning with specialist advisers.
Commercial scale
Sales model design for clinician and institutional buyers.